First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2014-04-16 07:14:28Open Document File Size: 1,14 MBShare Result on FacebookCompanyJohn Wiley & Sons Inc. / Electronics Engineers Inc. / HHS/HRSA / /CountryUnited States / /EventBusiness Partnership / /FacilityNational Institute of Health / Scaffold Cellularization / /IndustryTermclinical applications / potential applications / implantation site / end product applications / organ systems / encapsulation technology / end products / immunoisolation systems / mechanical devices / technology development / organ-like model systems / non biological devices / left ventricular assist devices / /MedicalConditionhyperplastic left heart syndrome / cardiovascular disorders / congenital defects / disease / atherosclerosis / chronic shortage / acute myocardial failure / end-stage heart failure / /MedicalTreatmentliver transplants / surgery / /OrganizationNational Institute of Health / National Science Foundation / UNOS / US Government / RI AL / Foundations mission / Minneapolis Medical Research Foundation / /PersonM. V. Sefton / R. Nerem / J. P. Vacanti / P. Dunnill / A. Atala / R. Langer / C. Mason / Eugene Bell / Ravi Birla / /Positionresearcher / collaborative model for tissue engineering research / /Technologybiomaterials / TISSUE ENGINEERING / transplantation / stem cells / regenerative medicine / apoptosis / specific technology / encapsulation technology / /SocialTag |